Pfizer’s RSV Vaccine: Two Positive Votes Don’t Necessarily Add Up To AdComm Endorsement

 
• By Sarah Karlin-Smith

Pfizer got positive standalone votes on safety and efficacy for its RSV vaccine in older adults at a US FDA advisory committee, but only three advisors – a minority of the 12-member panel – endorsed both the safety and effectiveness of the firm’s candidate.

math equation without the answer
VRBPAC vote totals obscure panel’s conflicted stance on Pfizer’s RSV vaccine • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers